ABSTRACT
In contemporary global contexts characterized by persistent armed conflicts—such as those in Ukraine and the Middle East—healthcare system management extends beyond routine hospital operations and constitutes a critical component of overall health system resilience. Strategic decisions on resource allocation and contingency planning can substantially influence the probability of secondary public health outbreaks, potentially mitigating or exacerbating widespread crises in short timeframes. Medical diagnostic laboratories (hematology, microbiology, and immunology) play a central role in these settings by performing diagnostics and providing ongoing surveillance of biological threats, which can escalate rapidly amid wartime disruptions and lead to significant consequences. Reports from conflict zones document frequent disruptions to laboratory operations, including power outages, infrastructure damage from attacks, forced staff relocation, and security breaches such as theft. The biological risks persist irrespective of ceasefire agreements and necessitate ongoing preparedness and mitigation efforts. Healthcare leadership should therefore prioritize biosafety and biosecurity as core operational components, integrated into routine management rather than confined to emergency plan appendices, to effectively reduce associated risks.
